Ysios Capital targets biotech

The fund is being marketed as the largest biotechnology venture capital fund to be launched in Spain. The fund will target investments of between €500,000 and €4m in companies seeking first-round funding, later stage enterprises will also invest in pharmaceutical spin-offs.